| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1700064 | 重组抗VEGFR2全人单克隆抗体注射液 | Recombinant anti-VEGFR2 human monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2017-07-13 | 上海复宏汉霖生物技术股份有限公司 | Shanghai Henlius Biotech Co Ltd | Certificate Issued | 2018-01-17 | view |
| CXSL1800113 | 重组抗VEGFR2全人单克隆抗体注射液 | Recombinant anti-VEGFR2 human monoclonal antibody | Injection | Biological Products(2) | New Drug Application | 2018-11-14 | 齐鲁制药有限公司 | QILU Pharmaceutical Co Ltd | In Review | 2018-11-12 | view |